Related Experiment Video
Updated: Jan 27, 2026

Using the E1A Minigene Tool to Study mRNA Splicing Changes
Published on: April 22, 2021
Aberrant mRNA splicing generates oncogenic RNA isoforms and contributes to the development and progression of
Juthamas Yosudjai1, Sopit Wongkham2, Siwanon Jirawatnotai3
1Department of Biochemistry, Faculty of Medical Science, Naresuan University, Phitsanulok 65000, Thailand.
Abstract:
Cholangiocarcinoma is a lethal biliary cancer, with an unclear molecular pathogenesis. Alternative splicing is a post-transcriptional modification that generates mature mRNAs, which are subsequently translated into proteins. Aberrant alternative splicing has been reported to serve a role in tumor initiation, maintenance and metastasis in several types of human cancer, including cholangiocarcinoma. In this review, the aberrant splicing of genes and the functional contributions of the spliced genes, in the carcinogenesis, progression and aggressiveness of cholangiocarcinoma are summarized. In addition, factors that influence this aberrant splicing that may be relevant as therapeutic targets or prognosis markers for cholangiocarcinoma are discussed.
Insights
Aberrant alternative splicing plays a key role in cholangiocarcinoma (biliary cancer) development and progression. Understanding these splicing changes may reveal new therapeutic targets and prognosis markers for this lethal disease.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Cholangiocarcinoma (CCA) is a lethal biliary tract cancer with poorly understood molecular mechanisms.
- Alternative splicing, a process generating mRNA diversity, is increasingly implicated in cancer.
- Aberrant splicing is observed in various cancers, including CCA, affecting tumor initiation, maintenance, and metastasis.
Purpose of the Study:
- To review the aberrant splicing of genes in cholangiocarcinoma.
- To summarize the functional roles of alternatively spliced genes in CCA carcinogenesis, progression, and aggressiveness.
- To discuss factors influencing aberrant splicing as potential therapeutic targets or prognostic markers.
Main Methods:
- Literature review of studies on alternative splicing in cholangiocarcinoma.
- Analysis of gene splicing patterns and their functional impact.
- Identification of factors influencing aberrant splicing relevant to CCA.
Main Results:
- Aberrant alternative splicing contributes significantly to cholangiocarcinoma development and progression.
- Specific spliced genes and their functions in CCA aggressiveness are identified.
- Factors influencing aberrant splicing present potential therapeutic and prognostic avenues.
Conclusions:
- Alternative splicing is a critical factor in cholangiocarcinoma pathogenesis.
- Targeting aberrant splicing mechanisms offers potential therapeutic strategies for CCA.
- Splicing alterations may serve as valuable biomarkers for cholangiocarcinoma prognosis.
Related Concept Videos
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alternative RNA Splicing
RNA Splicing
Pre-mRNA Processing: RNA Splicing
Nuclear Export of mRNA
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...

